Physician profile
Michael Heise
NPI 1740619840
$2,077.15
in general payments reported to CMS, 2019-2025
25 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $679 · 2023: $549 · 2024: $359 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $538.54 | 2021-2025 | Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $253.71 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $202.44 | 2021-2025 | Mounjaro, Trulicity, Zepbound |
| Novartis Pharmaceuticals Corporation | $180.77 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.25 | 2022-2024 | Xifaxan |
| Pfizer INC. | $104.59 | 2023-2025 | |
| Mylan Specialty L.P. | $95.68 | 2022-2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $86.68 | 2022-2024 | Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $83.51 | 2021-2022 | |
| Amgen INC. | $75.56 | 2022-2025 | Repatha, Otezla, Repatha |
| Esperion Therapeutics, INC. | $40.86 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.69 | 2022 | |
| Phathom Pharmaceuticals, INC. | $39.39 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $38.63 | 2021-2022 | |
| Astellas Pharma US INC | $31.98 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $23.49 | 2021 | |
| Eisai INC. | $17.36 | 2021 | |
| Amarin Pharma, INC. | $17.30 | 2021 | |
| Philips North America LLC | $16.20 | 2023 | |
| Exact Sciences Corporation | $15.90 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $13.38 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $12.97 | 2023 | |
| Merck Sharp & Dohme LLC | $12.53 | 2021 | |
| Abbott Laboratories | $12.05 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Heise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.